In the mammalian mesencephalon, virtually all serotoninergic neurons are lo
cated in the raphe nuclei and the adjacent reticular formation. Pharmacolog
ical evidence obtained in rodents suggests that terminal and somatodendriti
c autoreceptors controlling serotonin (5-hydroxytryptamine, 5-HT) release b
elong to the 5-HT1B/D subtype of receptors, whereas somatodendritic autorec
eptors controlling neuronal cell firing are predominantly of the 5-HT1A sub
type. This study investigated the presence of h5-HT1D and h5-HT1B receptor
mRNA within the subdivisions of the dorsal raphe of post-mortem human brain
s by means of in situ hybridisation. Although differences in the labelling
intensity, which may be caused by different pre- and/or post-mortem conditi
ons, were obvious among the specimens, all brains expressed both the h5-HT1
D and the h5-HT1B mRNA in dorsal raphe neurons. In comparison to h5-HT1D mR
NA, expression of h5-HT1B mRNA was slightly more abundant. Information on t
he existence and localisation of h5-HT1D and h5-HT1B receptors in human dor
sal raphe neurons confirms that both subtypes may serve an autoreceptor fun
ction in humans. This finding is of pharmacological relevance since these r
eceptors are potential new targets for therapeutic interventions in psychia
tric disorders such as depression and anxiety.